Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Frank Scott

Concepts (325)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Bowel Diseases
28
2026
360
8.490
Why?
Crohn Disease
16
2025
256
5.530
Why?
Gastrointestinal Agents
7
2025
67
3.370
Why?
Gastroenterology
7
2025
186
2.120
Why?
Colitis, Ulcerative
9
2025
145
2.070
Why?
Infliximab
10
2022
111
1.540
Why?
Intestinal Obstruction
3
2021
53
1.470
Why?
Tissue Adhesions
3
2021
33
1.250
Why?
Immunosuppressive Agents
6
2020
859
1.250
Why?
Adrenal Cortex Hormones
4
2022
502
1.120
Why?
Tumor Necrosis Factor-alpha
10
2023
1225
1.110
Why?
Antibodies, Monoclonal, Humanized
5
2025
917
1.080
Why?
Algorithms
7
2026
1791
1.010
Why?
Intestine, Small
2
2021
158
0.960
Why?
Patient Acceptance of Health Care
5
2026
879
0.950
Why?
Biological Products
4
2026
243
0.930
Why?
Ustekinumab
2
2025
18
0.890
Why?
JC Virus
2
2015
23
0.870
Why?
Leukoencephalopathy, Progressive Multifocal
2
2015
38
0.860
Why?
Azathioprine
5
2021
51
0.800
Why?
Bone Diseases, Metabolic
1
2023
64
0.790
Why?
Humans
91
2026
142526
0.790
Why?
Abdominal Abscess
1
2022
25
0.750
Why?
Abdomen
2
2021
140
0.740
Why?
Esophageal Neoplasms
6
2022
343
0.730
Why?
Drug Monitoring
1
2026
396
0.730
Why?
Gastrointestinal Hemorrhage
3
2023
135
0.680
Why?
Postoperative Complications
3
2021
2862
0.670
Why?
Severity of Illness Index
9
2025
2927
0.660
Why?
Retrospective Studies
27
2026
16626
0.660
Why?
Splints
1
2020
15
0.660
Why?
Capsule Endoscopy
1
2020
18
0.650
Why?
Anti-Bacterial Agents
5
2018
1881
0.650
Why?
Antibodies, Viral
2
2015
664
0.640
Why?
Biosimilar Pharmaceuticals
1
2020
27
0.630
Why?
Biomedical Research
2
2019
692
0.610
Why?
Barrett Esophagus
4
2023
166
0.610
Why?
Radius Fractures
1
2020
67
0.610
Why?
Quality-Adjusted Life Years
5
2021
112
0.590
Why?
Spondylarthritis
3
2025
50
0.580
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2021
449
0.580
Why?
Colonoscopy
7
2024
251
0.570
Why?
Hospitalization
4
2026
2293
0.560
Why?
Drug Utilization
1
2019
166
0.560
Why?
Adult
37
2026
39715
0.560
Why?
Intestinal Fistula
1
2018
17
0.560
Why?
Colonic Diseases
1
2018
36
0.550
Why?
Health Resources
1
2019
129
0.550
Why?
Tuberculin Test
1
2017
36
0.550
Why?
Surgical Procedures, Operative
1
2021
273
0.540
Why?
Pericardium
1
2018
60
0.540
Why?
Cost-Benefit Analysis
5
2021
618
0.540
Why?
Biological Factors
2
2023
39
0.530
Why?
Epstein-Barr Virus Infections
1
2018
100
0.520
Why?
Models, Statistical
2
2019
677
0.520
Why?
Latent Tuberculosis
1
2017
70
0.510
Why?
Male
48
2026
70910
0.510
Why?
Middle Aged
37
2026
35049
0.500
Why?
Time-to-Treatment
2
2019
227
0.500
Why?
Mass Screening
4
2021
1325
0.500
Why?
Colorectal Neoplasms
6
2024
824
0.480
Why?
Remission Induction
3
2025
306
0.480
Why?
Treatment Outcome
14
2025
11298
0.480
Why?
Antibodies, Monoclonal
4
2021
1471
0.470
Why?
Natalizumab
1
2015
40
0.450
Why?
Radius
1
2015
52
0.450
Why?
Heart Diseases
1
2018
339
0.430
Why?
Fracture Fixation
1
2015
84
0.430
Why?
Mycobacterium tuberculosis
1
2017
327
0.420
Why?
Models, Theoretical
1
2018
585
0.420
Why?
Age Factors
5
2025
3316
0.420
Why?
Female
44
2026
76624
0.410
Why?
Practice Patterns, Physicians'
3
2024
1353
0.400
Why?
Leukocyte L1 Antigen Complex
2
2026
39
0.400
Why?
Aged
27
2024
25117
0.400
Why?
Markov Chains
3
2020
126
0.390
Why?
Lymphoma
1
2014
228
0.380
Why?
Risk Factors
17
2025
10593
0.380
Why?
Drug Therapy, Combination
4
2024
1053
0.370
Why?
Adalimumab
3
2021
55
0.370
Why?
Communicable Diseases
1
2014
165
0.360
Why?
Patient Discharge
2
2023
920
0.360
Why?
Feces
3
2026
494
0.350
Why?
United Kingdom
5
2021
325
0.350
Why?
Gastroenterologists
2
2022
17
0.350
Why?
Professional Competence
1
2012
96
0.350
Why?
Disease Management
3
2021
641
0.340
Why?
Carcinoma, Squamous Cell
1
2016
643
0.330
Why?
Cohort Studies
10
2025
5858
0.330
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2013
351
0.330
Why?
Research Design
2
2019
1113
0.330
Why?
Spondylitis, Ankylosing
2
2021
47
0.330
Why?
Research Personnel
1
2012
177
0.320
Why?
Fractures, Bone
1
2015
409
0.320
Why?
Gastroesophageal Reflux
2
2023
244
0.320
Why?
Adenoma
3
2024
218
0.320
Why?
Colonic Polyps
2
2024
82
0.320
Why?
United States
17
2025
15447
0.300
Why?
Proportional Hazards Models
5
2021
1284
0.300
Why?
Urinary Bladder Neoplasms
3
2017
258
0.290
Why?
Pediatric Obesity
1
2016
617
0.290
Why?
Janus Kinase Inhibitors
2
2025
27
0.290
Why?
Societies, Medical
4
2025
866
0.280
Why?
Skin Neoplasms
1
2016
856
0.280
Why?
Randomized Controlled Trials as Topic
3
2025
1642
0.270
Why?
Incidence
8
2021
2826
0.270
Why?
Quality of Life
2
2021
3064
0.270
Why?
Electronic Health Records
6
2022
1144
0.260
Why?
Mortality
2
2020
362
0.250
Why?
Databases, Factual
7
2018
1458
0.250
Why?
Consensus
2
2025
546
0.240
Why?
Neoplasm Recurrence, Local
3
2017
1087
0.240
Why?
Maintenance Chemotherapy
1
2025
38
0.240
Why?
Radiography
2
2020
846
0.230
Why?
Adenocarcinoma
3
2022
904
0.230
Why?
Population Surveillance
2
2021
485
0.230
Why?
Referral and Consultation
2
2023
822
0.230
Why?
Induction Chemotherapy
1
2025
84
0.230
Why?
Antifungal Agents
2
2016
147
0.220
Why?
Aged, 80 and over
10
2020
8020
0.220
Why?
Evidence-Based Medicine
2
2025
721
0.220
Why?
Case-Control Studies
8
2021
3604
0.220
Why?
Recurrence
5
2021
1111
0.210
Why?
Delivery of Health Care
2
2021
952
0.210
Why?
Esophageal Stenosis
2
2014
56
0.210
Why?
Surveys and Questionnaires
8
2025
5994
0.200
Why?
C-Reactive Protein
1
2026
417
0.200
Why?
Gastrointestinal Microbiome
2
2022
727
0.200
Why?
Diagnosis, Computer-Assisted
1
2024
92
0.200
Why?
Obesity
1
2017
3027
0.200
Why?
Protective Factors
2
2021
96
0.200
Why?
Esophagitis, Peptic
1
2023
17
0.200
Why?
Colectomy
2
2021
107
0.200
Why?
Models, Economic
2
2020
61
0.190
Why?
Glucocorticoids
2
2018
535
0.190
Why?
Logistic Models
6
2018
2102
0.190
Why?
Absorptiometry, Photon
1
2023
268
0.190
Why?
Prognosis
4
2019
4112
0.190
Why?
Comparative Effectiveness Research
2
2024
164
0.180
Why?
Cellulitis
1
2022
55
0.180
Why?
Medical Marijuana
1
2024
124
0.180
Why?
Odds Ratio
4
2018
1057
0.180
Why?
Insurance, Health
1
2024
299
0.180
Why?
Amputation, Traumatic
1
2021
21
0.170
Why?
Necrosis
1
2022
246
0.170
Why?
Finger Injuries
1
2021
26
0.170
Why?
Rectal Fistula
1
2021
27
0.170
Why?
Liver Transplantation
2
2021
811
0.170
Why?
Aftercare
1
2023
218
0.170
Why?
Pancreatic Neoplasms
2
2021
895
0.170
Why?
Vascular Surgical Procedures
2
2021
341
0.170
Why?
Prevalence
4
2025
2817
0.170
Why?
Follow-Up Studies
4
2021
5270
0.170
Why?
Gynecologic Surgical Procedures
1
2021
66
0.160
Why?
Cystectomy
2
2017
42
0.160
Why?
Utilization Review
1
2020
41
0.160
Why?
Esophagoscopy
2
2022
219
0.160
Why?
Sugars
1
2020
42
0.160
Why?
Practice Guidelines as Topic
2
2025
1552
0.160
Why?
Digestive System Surgical Procedures
1
2021
109
0.160
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2020
37
0.160
Why?
Carcinoma
1
2021
230
0.160
Why?
Bone Plates
1
2020
79
0.160
Why?
Bone Density
1
2023
499
0.150
Why?
Artificial Intelligence
1
2024
353
0.150
Why?
Tryptophan
1
2021
180
0.150
Why?
Quality Assurance, Health Care
1
2021
320
0.150
Why?
Urologic Surgical Procedures
1
2021
118
0.150
Why?
Metagenomics
1
2021
180
0.150
Why?
Diabetes Mellitus
2
2021
1083
0.150
Why?
Hospitals
2
2021
690
0.150
Why?
Sensitivity and Specificity
1
2024
1977
0.150
Why?
Deglutition Disorders
1
2021
151
0.150
Why?
Hospitals, Veterans
1
2020
255
0.150
Why?
Obesity, Morbid
1
2023
277
0.150
Why?
Chronic Disease
2
2022
1815
0.150
Why?
Child
6
2023
22562
0.150
Why?
Metabolomics
2
2022
712
0.140
Why?
Diverticulum
1
2018
12
0.140
Why?
Job Satisfaction
1
2021
229
0.140
Why?
Hematemesis
1
2018
4
0.140
Why?
Symptom Assessment
2
2017
132
0.140
Why?
Health Care Costs
1
2021
422
0.140
Why?
Fracture Fixation, Internal
1
2020
202
0.140
Why?
Range of Motion, Articular
1
2020
415
0.140
Why?
Infant
5
2020
9908
0.140
Why?
Carcinoma, Pancreatic Ductal
1
2021
288
0.140
Why?
Intestines
1
2021
355
0.140
Why?
Endoscopic Mucosal Resection
1
2017
27
0.130
Why?
Clostridium Infections
1
2018
74
0.130
Why?
Fatal Outcome
1
2018
311
0.130
Why?
Arthritis, Rheumatoid
2
2016
1209
0.130
Why?
Ambulatory Care
1
2021
598
0.130
Why?
Quality of Health Care
1
2021
649
0.130
Why?
Risk Assessment
3
2016
3562
0.130
Why?
Cystadenoma, Mucinous
1
2016
10
0.120
Why?
Continuity of Patient Care
1
2019
284
0.120
Why?
Budesonide
1
2016
56
0.120
Why?
Itraconazole
1
2016
9
0.120
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2016
61
0.120
Why?
Pharmacoepidemiology
1
2015
22
0.120
Why?
Endoscopy, Gastrointestinal
3
2023
231
0.120
Why?
Pancreatic Diseases
1
2016
67
0.120
Why?
Guideline Adherence
1
2020
565
0.120
Why?
Neoplasms, Second Primary
1
2016
98
0.120
Why?
Cysts
1
2016
113
0.120
Why?
Cross-Sectional Studies
4
2025
5700
0.110
Why?
Epiphyses
1
2015
26
0.110
Why?
Analgesics, Opioid
1
2024
1123
0.110
Why?
Hyperlipidemias
1
2016
126
0.110
Why?
Data Accuracy
1
2015
63
0.110
Why?
Child, Preschool
5
2016
11634
0.110
Why?
Antirheumatic Agents
1
2018
308
0.110
Why?
Arthritis, Juvenile
1
2015
55
0.110
Why?
Polypharmacy
1
2015
90
0.110
Why?
Psoriasis
1
2016
114
0.110
Why?
Elbow Joint
1
2015
75
0.110
Why?
Adolescent
7
2019
22326
0.110
Why?
Hedgehog Proteins
1
2016
200
0.110
Why?
Neoplasms
2
2023
2761
0.110
Why?
Interferon-gamma
1
2017
790
0.110
Why?
Prescription Drugs
1
2015
112
0.110
Why?
Dilatation
1
2014
69
0.110
Why?
Microbiota
1
2022
756
0.100
Why?
Cholesterol
1
2016
404
0.100
Why?
Burnout, Professional
1
2021
461
0.100
Why?
Young Adult
7
2019
13878
0.100
Why?
Immunologic Factors
1
2016
249
0.100
Why?
Anastomosis, Surgical
1
2014
159
0.100
Why?
Streptococcal Infections
1
2016
158
0.100
Why?
Virus Diseases
1
2016
218
0.100
Why?
Radiation Injuries
1
2014
149
0.100
Why?
Foreign Bodies
1
2014
108
0.100
Why?
Renal Insufficiency, Chronic
1
2019
633
0.100
Why?
Disease Progression
2
2021
2831
0.100
Why?
Early Detection of Cancer
3
2022
441
0.100
Why?
Reoperation
1
2015
600
0.090
Why?
Registries
1
2021
2227
0.090
Why?
Primary Health Care
2
2022
1768
0.090
Why?
Diabetes Complications
1
2013
222
0.090
Why?
Epidemiology
1
2012
33
0.090
Why?
Patient Readmission
1
2017
703
0.090
Why?
Physical Therapy Modalities
1
2015
323
0.090
Why?
Research Support as Topic
1
2012
81
0.090
Why?
Tissue and Organ Procurement
1
2015
330
0.090
Why?
Endoscopy
1
2014
327
0.090
Why?
Biomarkers
2
2020
4207
0.090
Why?
Age Distribution
1
2012
396
0.090
Why?
Time Factors
5
2021
7006
0.080
Why?
Predictive Value of Tests
1
2016
2081
0.080
Why?
Physicians
1
2019
937
0.080
Why?
Veterans
1
2021
1531
0.080
Why?
Medicare
3
2021
808
0.070
Why?
Prospective Studies
4
2024
7862
0.070
Why?
Drug Prescriptions
2
2024
274
0.070
Why?
Laparoscopy
1
2012
471
0.070
Why?
Neoplasm Staging
2
2022
1404
0.060
Why?
Emergency Service, Hospital
1
2019
2251
0.060
Why?
Academic Medical Centers
2
2021
531
0.060
Why?
Kaplan-Meier Estimate
2
2020
914
0.060
Why?
Pennsylvania
2
2017
135
0.060
Why?
Sex Factors
2
2025
2074
0.060
Why?
Breast Neoplasms
1
2016
2272
0.050
Why?
Survival Analysis
2
2017
1328
0.050
Why?
Regression Analysis
2
2017
1013
0.050
Why?
Multivariate Analysis
2
2017
1508
0.050
Why?
Piperidines
1
2024
220
0.050
Why?
Insurance Coverage
1
2024
240
0.050
Why?
Gastrectomy
1
2023
140
0.040
Why?
Replantation
1
2021
31
0.040
Why?
Cost Savings
1
2021
86
0.040
Why?
Review Literature as Topic
1
2021
49
0.040
Why?
Granzymes
1
2021
50
0.040
Why?
Documentation
1
2023
194
0.040
Why?
Training Support
1
2021
36
0.040
Why?
Fingers
1
2021
106
0.040
Why?
Salaries and Fringe Benefits
1
2021
56
0.040
Why?
Morbidity
1
2021
321
0.040
Why?
Hand
1
2021
165
0.040
Why?
Metabolic Networks and Pathways
1
2021
185
0.040
Why?
Perception
1
2022
378
0.040
Why?
SEER Program
1
2020
219
0.040
Why?
Reproducibility of Results
2
2019
3362
0.040
Why?
Dysbiosis
1
2021
182
0.040
Why?
Disease Susceptibility
1
2021
353
0.040
Why?
Medicine
1
2021
125
0.040
Why?
Physician's Role
1
2021
218
0.040
Why?
Delayed Diagnosis
1
2019
91
0.040
Why?
Gene Expression Regulation, Bacterial
1
2021
325
0.040
Why?
Age of Onset
1
2020
545
0.040
Why?
Career Choice
1
2021
234
0.040
Why?
Pharmacovigilance
1
2018
24
0.040
Why?
Mathematical Concepts
1
2018
36
0.030
Why?
Margins of Excision
1
2017
48
0.030
Why?
Smoking
1
2025
1579
0.030
Why?
Decision Support Systems, Clinical
1
2021
267
0.030
Why?
Mercaptopurine
1
2016
15
0.030
Why?
Prednisone
1
2018
231
0.030
Why?
Hip Fractures
1
2018
85
0.030
Why?
Etanercept
1
2016
61
0.030
Why?
Longitudinal Studies
1
2024
2980
0.030
Why?
Pilot Projects
1
2022
1829
0.030
Why?
Survival Rate
1
2021
1995
0.030
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2016
57
0.030
Why?
Computational Biology
1
2021
673
0.030
Why?
Clinical Competence
1
2024
1223
0.030
Why?
Streptococcus pyogenes
1
2016
42
0.030
Why?
Decision Making
1
2023
957
0.030
Why?
Glomerular Filtration Rate
1
2019
771
0.030
Why?
Cause of Death
1
2018
456
0.030
Why?
Methotrexate
1
2016
255
0.030
Why?
Weight Loss
1
2021
803
0.030
Why?
Intestinal Mucosa
1
2021
654
0.030
Why?
Bias
1
2016
208
0.030
Why?
Statistics, Nonparametric
1
2015
432
0.030
Why?
Neoplasm Invasiveness
1
2016
512
0.030
Why?
Gene Expression Profiling
1
2021
1773
0.030
Why?
Mental Recall
1
2015
212
0.030
Why?
Computer Simulation
1
2018
1018
0.030
Why?
Waiting Lists
1
2015
254
0.030
Why?
Medicaid
1
2018
457
0.030
Why?
Anticoagulants
1
2018
725
0.020
Why?
T-Lymphocytes
1
2021
2016
0.020
Why?
Respiratory Tract Infections
1
2015
389
0.020
Why?
Cardiovascular Diseases
1
2018
2103
0.010
Why?
Scott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)